Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cd4 Infection'

Cd4 Infection published presentations and documents on DocSlides.

Correctly modeling CD4 cell count in Cox regression analysi
Correctly modeling CD4 cell count in Cox regression analysi
by myesha-ticknor
Allison Dunning, M.S.. Research Biostatistician. ...
1 Risk of progression to AIDS or death in relation to CD4 c
1 Risk of progression to AIDS or death in relation to CD4 c
by celsa-spraggs
Heiner C. Bucher for the Opportunistic Infections...
NKT CD4
NKT CD4
by min-jolicoeur
% of max. DCFDA. 12wk. 3wk. CD44-high. gated. Fig...
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
by gagnon
Allison Dunning, M.S.. Research Biostatistician. W...
A point of care diagnostic device for monitoring CD4 levels in HIV patients in a resource poor sett
A point of care diagnostic device for monitoring CD4 levels in HIV patients in a resource poor sett
by sadie
Group 14:. Lina. . Aboulmouna. Peter . DelNero. P...
INR IR Anti-CD4 IgG levels
INR IR Anti-CD4 IgG levels
by hadley
Plasma sCD4 . levels. NK . protein. . release. NK...
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of ant
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of ant
by daisy
Jean-Michel Molina, . Birgit. . Grund. , Fred . G...
BD Horizon Fixable Viability Stain (FVS) ReagentsBD Horizon™ Fixable Viability Stain (FVS) reagents for the violet (FVS450 and FVS510), blue (FVS520), yellow-green (FVS570 and FVS620, also excitable by the blue laser), and red lasers (FVS660, FVS700,
BD Horizon Fixable Viability Stain (FVS) ReagentsBD Horizon™ Fixable Viability Stain (FVS) reagents for the violet (FVS450 and FVS510), blue (FVS520), yellow-green (FVS570 and FVS620, also excitable by the blue laser), and red lasers (FVS660, FVS700,
by tatyana-admore
Figure 1. CD3+CD4+ live61%40%CD3+CD4+ no discrimin...
South Africa’s
South Africa’s
by marina-yarberry
experiences and future plans for CD4 and viral lo...
Expanding HIV testing and the use
Expanding HIV testing and the use
by kittie-lecroy
of ARVs for treatment and prevention. Getting to ...
Identification and Initial Characterization of a Mouse with
Identification and Initial Characterization of a Mouse with
by ellena-manuel
Andrew Johnson, Brady Evans and Sophia Sarafova. ...
International Lab Branch
International Lab Branch
by liane-varnes
Center for Global Health / Division of Global HI...
Measuring the latent HIV Reservoir
Measuring the latent HIV Reservoir
by phoebe-click
HIV Cure Research Training Curriculum. Scientific...
HIV Cure Research Training Curriculum
HIV Cure Research Training Curriculum
by danika-pritchard
Nicolas . Chomont. , University of Montreal. Rich...
Switch to DRV/r
Switch to DRV/r
by mitsue-stanley
monotherapy. MONOI. MONET. PROTEA. DRV600. Design...
S3 Fig.
S3 Fig.
by myesha-ticknor
Flow cytometry gating strategies for cells isolat...
Suboptimal immune response among adults on first-line ant
Suboptimal immune response among adults on first-line ant
by tatiana-dople
IeDEA. East Africa cohort. . Authors: . Nakanja...
Supplemental Digital Content 5 -
Supplemental Digital Content 5 -
by test
Figure 1. . CD4. HIV-2 subgroup and control . h...
Cytokinereceptor
Cytokinereceptor
by alida-meadow
TCR TCR TCR BTLA CCR7 CD62L CD3 IL-7R IL-7R NK1.1 ...
  Integration of TB and HIV:
  Integration of TB and HIV:
by yoshiko-marsland
marked reductions in TB incidence . after introdu...
WHO Guidelines
WHO Guidelines
by ellena-manuel
for . treatment monitoring. Nathan . Ford. Dept....
Regulatory T cells
Regulatory T cells
by luanne-stotts
Control of potential T cell self-reactivity: tole...
Should we treat
Should we treat
by trish-goza
HIV Controllers ?. IAS 2013. Pr Olivier Lambotte....
Role of Adaptive vs. Innate Immune Activation in
Role of Adaptive vs. Innate Immune Activation in
by yoshiko-marsland
non-AIDS Morbidity. Peter W. Hunt, MD. Associate ...
Target cell availability dictates mother-to-infant transmis
Target cell availability dictates mother-to-infant transmis
by olivia-moreira
Ann Chahroudi, MD, PhD. Division of Pediatric Inf...
Late HIV Diagnoses, Georgia,
Late HIV Diagnoses, Georgia,
by alida-meadow
2011-2012. Background. Late . HIV diagnosis . is ...
IAS 2014, Melbourne
IAS 2014, Melbourne
by tawny-fly
Mechanisms of non-pathogenicity in HIV- Lessons f...
Early Access to ART for All (EAAA)
Early Access to ART for All (EAAA)
by kittie-lecroy
Swaziland Implementation . “Treat All” . Pilo...
Intracellular Cytokine Staining (ICS)
Intracellular Cytokine Staining (ICS)
by karlyn-bohler
Flow . Cytometry. Assay. 1. Kent J. . Weinhold. ...
High Rates of Tuberculosis in Patients Accessing HAART in R
High Rates of Tuberculosis in Patients Accessing HAART in R
by luanne-stotts
Kogieleum. . Naidoo . on behalf of. . Quarraish...
Monitoring Delays in Adopting WHO
Monitoring Delays in Adopting WHO
by myesha-ticknor
. HIV Treatment . G. uidelines in Low- and Middl...
Expanding HIV testing and the use
Expanding HIV testing and the use
by briana-ranney
of ARVs for treatment and prevention. Getting to ...
1 Effector T Cell Subsets, Cytokines
1 Effector T Cell Subsets, Cytokines
by ellena-manuel
. Abul K. . Abbas. UCSF. FOCiS. 2. Lecture outli...
XIII International Asian School-seminar
XIII International Asian School-seminar
by aaron
“. Problems of complex . system’s. . optimiz...
Michael S. Saag , MD Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Georgia HIV Care Continuum Update:
Georgia HIV Care Continuum Update:
by test
Persons Living with HIV. , 2016, and Persons Diag...
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessat
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessat
by tawny-fly
Avy . Violari, . Mark . Cotton, . Louise . Kuhn, ...
HIV Care Continuum New Diagnoses, 2011, Atlanta Eligible Metropolitan Area (EMA)
HIV Care Continuum New Diagnoses, 2011, Atlanta Eligible Metropolitan Area (EMA)
by debby-jeon
Persons . with HIV . Engaged . in S. elected . S....
HIV Care Continuum New Diagnoses
HIV Care Continuum New Diagnoses
by yoshiko-marsland
, . Georgia, . 2011 . Persons . with HIV . Engage...
Treatment Eligibility among Men Testing HIV-Positive in Voluntary Medical Male Circumcision (VMMC)
Treatment Eligibility among Men Testing HIV-Positive in Voluntary Medical Male Circumcision (VMMC)
by natalia-silvester
Authors: . Virgile. . Kikaya. , Kelly Curran, . ...